Understanding COVID-19 Vaccine Immunity in Tissue and Blood
Sponsor
Stanford University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05682625
Collaborator
National Institute of Allergy and Infectious Diseases (NIAID) (NIH)
10
1
60
0.2
Study Details
Study Description
Brief Summary
The purpose of this study is to understand the effects of COVID-19 vaccines on the immune system and how the COVID-19 vaccines provide protection and induce long term memory. Adults who are receiving a COVID-19 vaccine will be invited to participate in this study.
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Study Type:
Observational
Anticipated Enrollment
:
10 participants
Observational Model:
Case-Only
Time Perspective:
Prospective
Official Title:
Understanding COVID-19 Vaccine Immunity in Tissue and Blood
Anticipated Study Start Date
:
Jan 1, 2023
Anticipated Primary Completion Date
:
Jan 1, 2028
Anticipated Study Completion Date
:
Jan 1, 2028
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Participants Adults who are receiving a COVID-19 vaccine |
Other: No intervention
No intervention
|
Outcome Measures
Primary Outcome Measures
- Testing immune response to the COVID-19 vaccine over time [1 day]
- Testing immune response to the COVID-19 vaccine over time [7 days]
- Testing immune response to the COVID-19 vaccine over time [28 days]
Eligibility Criteria
Criteria
Ages Eligible for Study:
18 Years
and Older
Sexes Eligible for Study:
All
Inclusion Criteria:
- Adults 18yrs old and higher who are receiving a COVID-19 vaccine
Exclusion Criteria:
-
Pregnancy
-
Patients with contraindications for lymph node biopsy
-
Active cancer
-
Current use of immunosuppression drugs
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Stanford University | Palo Alto | California | United States | 94304 |
Sponsors and Collaborators
- Stanford University
- National Institute of Allergy and Infectious Diseases (NIAID)
Investigators
- Principal Investigator: R. Sharon Chinthrajah, MD, Stanford University, Sean N. Parker Center for Allergy and Asthma Research
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.Responsible Party:
R. Sharon Chinthrajah,
Associate professor,
Stanford University
ClinicalTrials.gov Identifier:
NCT05682625
Other Study ID Numbers:
- IRB-67705
- 1U19AI167903-01
First Posted:
Jan 12, 2023
Last Update Posted:
Jan 12, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by R. Sharon Chinthrajah,
Associate professor,
Stanford University
Additional relevant MeSH terms: